{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:04:37Z","timestamp":1784037877720,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tmaid.2026.102981","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:51:15Z","timestamp":1776408675000},"page":"102981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Safety and tolerability of benznidazole in older patients with chronic Chagas disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Jaime","family":"Vega-Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-1829","authenticated-orcid":false,"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"S\u00e1nchez-Montalv\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Serre-Delcor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Pou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroa","family":"Silgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Espinosa-Pereiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ednez-Campreci\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Roig-Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sulleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2026.102981_bib1","first-page":"33","article-title":"Chagas disease in Latin America: an epidemiological update based on 2010 estimates","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.tmaid.2026.102981_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101040","article-title":"Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis","volume":"46","author":"Nepomuceno de Andrade","year":"2024","journal-title":"The Lancet Regional Health Europe"},{"key":"10.1016\/j.tmaid.2026.102981_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2026.102981_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006814","article-title":"Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study","volume":"12","author":"Cardoso","year":"2018","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2026.102981_bib5","first-page":"e124","article-title":"Randomized trial of benznidazole for chronic Chagas' Cardiomyopathy","volume":"373","author":"Ca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2026.102981_bib6","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1128\/AAC.04660-14","article-title":"Toxic profile of benznidazole in patients with chronic chagas disease: risk factors and comparison of the product from two different manufacturers","volume":"59","author":"Molina","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2026.102981_bib7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jac\/dkx516","article-title":"What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment","volume":"73","author":"Aldasoro","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2026.102981_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/292138","article-title":"Therapy of chagas disease: implications for levels of prevention","volume":"2012","author":"Sosa-Estani","year":"2012","journal-title":"J Trop Med"},{"key":"10.1016\/j.tmaid.2026.102981_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010386","article-title":"Use of benznidazole to treat chronic Chagas disease: an updated systematic review with a meta-analysis","volume":"16","author":"Crespillo-And\u00fajar","year":"2022","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2026.102981_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(14)60569-9","article-title":"Causes of international increases in older age life expectancy","volume":"385","author":"Mathers","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2026.102981_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actatropica.2007.05.019","article-title":"Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples","volume":"103","author":"Piron","year":"2007","journal-title":"Acta Trop"},{"key":"10.1016\/j.tmaid.2026.102981_bib12","doi-asserted-by":"crossref","first-page":"881.e1","DOI":"10.1016\/j.cmi.2021.11.021","article-title":"Association of HLA-B\u221735 and moderate or severe cutaneous reactions secondary to benznidazole treatment in chronic chagas disease","volume":"28","author":"Bosch-Nicolau","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmaid.2026.102981_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40264-018-0696-5","article-title":"Safety profile of benznidazole in the treatment of chronic chagas disease: experience of a referral Centre and systematic literature review with meta-analysis","volume":"41","author":"Crespillo-And\u00fajar","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.tmaid.2026.102981_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","article-title":"Benznidazole and posaconazole in eliminating parasites in asymptomatic T. Cruzi carriers: the STOP-CHAGAS trial","volume":"69","author":"Morillo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tmaid.2026.102981_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","article-title":"New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial","volume":"21","author":"Torrico","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2026.102981_bib16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2026.102981_bib17","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0506-2023","article-title":"Exploring the historical background and clinical implications of electrocardiogram in the context of chagas disease research","volume":"56","author":"Hasslocher-Moreno","year":"2023","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.tmaid.2026.102981_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.112.123612","article-title":"Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors","volume":"127","author":"Sabino","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.tmaid.2026.102981_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15072","article-title":"Risk of chronic cardiomyopathy among patients with the acute phase or indeterminate form of chagas disease: a systematic review and meta-analysis","volume":"3","author":"Chadalawada","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tmaid.2026.102981_bib20","first-page":"145","article-title":"Chagas disease: independent risk factor for stroke","volume":"40","author":"Lc","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.tmaid.2026.102981_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3899\/jrheum.090306","article-title":"Risk factors for clinical coronary heart disease in systemic lupus erythematosus: the lupus and atherosclerosis evaluation of risk (LASER) study","volume":"37","author":"Haque","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.tmaid.2026.102981_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.tmaid.2026.102981_bib23","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/eurheartj\/ehx362","article-title":"Infections, atherosclerosis, and coronary heart disease","volume":"38","author":"Pothineni","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tmaid.2026.102981_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004669","article-title":"Inflammation enhances the risks of stroke and death in chronic chagas disease patients","volume":"10","author":"Guedes","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2026.102981_bib25","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/ijc.23192","article-title":"Chronic inflammation and oxidative stress in human carcinogenesis","volume":"121","author":"Federico","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.tmaid.2026.102981_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.socscimed.2017.05.049","article-title":"The \u201cHispanic mortality paradox\u201d revisited: Meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants' mortality","volume":"186","author":"Shor","year":"2017","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.tmaid.2026.102981_bib27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1469-0691.12443","article-title":"Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile","volume":"20","author":"Salvador","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893926000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893926000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:11:40Z","timestamp":1784034700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893926000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"alternative-id":["S1477893926000311"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2026.102981","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and tolerability of benznidazole in older patients with chronic Chagas disease","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2026.102981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102981"}}